Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ovarian cancer creates a suppressive microenvironment to escape immune elimination.
Yigit R, Massuger LF, Figdor CG, Torensma R. Yigit R, et al. Gynecol Oncol. 2010 May;117(2):366-72. doi: 10.1016/j.ygyno.2010.01.019. Epub 2010 Feb 9. Gynecol Oncol. 2010. PMID: 20144842 Review.
Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer.
Yigit R, Figdor CG, Zusterzeel PL, Pots JM, Torensma R, Massuger LF. Yigit R, et al. Eur J Cancer. 2011 Aug;47(12):1883-9. doi: 10.1016/j.ejca.2011.03.026. Epub 2011 Apr 20. Eur J Cancer. 2011. PMID: 21514148
Cytokine profiles in cyst fluids from ovarian tumors reflect immunosuppressive state of the tumor.
Yigit R, Massuger LF, Zusterzeel PL, Pots J, Figdor CG, Torensma R. Yigit R, et al. Int J Gynecol Cancer. 2011 Oct;21(7):1241-7. doi: 10.1097/IGC.0b013e3182289ab1. Int J Gynecol Cancer. 2011. PMID: 21946293
Treatment Regimen, Surgical Outcome, and T-cell Differentiation Influence Prognostic Benefit of Tumor-Infiltrating Lymphocytes in High-Grade Serous Ovarian Cancer.
Wouters MC, Komdeur FL, Workel HH, Klip HG, Plat A, Kooi NM, Wisman GB, Mourits MJ, Arts HJ, Oonk MH, Yigit R, de Jong S, Melief CJ, Hollema H, Duiker EW, Daemen T, de Bruyn M, Nijman HW. Wouters MC, et al. Among authors: yigit r. Clin Cancer Res. 2016 Feb 1;22(3):714-24. doi: 10.1158/1078-0432.CCR-15-1617. Epub 2015 Sep 18. Clin Cancer Res. 2016. PMID: 26384738 Free article.
Survival of Ovarian Cancer Patients Is Independent of the Presence of DC and T Cell Subsets in Ascites.
Wefers C, Duiveman-de Boer T, Yigit R, Zusterzeel PLM, van Altena AM, Massuger LFAG, De Vries IJM. Wefers C, et al. Among authors: yigit r. Front Immunol. 2019 Jan 11;9:3156. doi: 10.3389/fimmu.2018.03156. eCollection 2018. Front Immunol. 2019. PMID: 30687337 Free PMC article.
CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
Workel HH, Komdeur FL, Wouters MC, Plat A, Klip HG, Eggink FA, Wisman GB, Arts HJ, Oonk MH, Mourits MJ, Yigit R, Versluis M, Duiker EW, Hollema H, de Bruyn M, Nijman HW. Workel HH, et al. Among authors: yigit r. Eur J Cancer. 2016 Jun;60:1-11. doi: 10.1016/j.ejca.2016.02.026. Epub 2016 Mar 31. Eur J Cancer. 2016. PMID: 27038842
Survival of patients with early-stage cervical cancer after abdominal or laparoscopic radical hysterectomy: a nationwide cohort study and literature review.
Wenzel HHB, Smolders RGV, Beltman JJ, Lambrechts S, Trum HW, Yigit R, Zusterzeel PLM, Zweemer RP, Mom CH, Bekkers RLM, Lemmens VEPP, Nijman HW, Van der Aa MA. Wenzel HHB, et al. Among authors: yigit r. Eur J Cancer. 2020 Jul;133:14-21. doi: 10.1016/j.ejca.2020.04.006. Epub 2020 May 15. Eur J Cancer. 2020. PMID: 32422504 Free article. Review.
Short-term surgical complications after radical hysterectomy-A nationwide cohort study.
Wenzel HHB, Kruitwagen RFPM, Nijman HW, Bekkers RLM, van Gorp T, de Kroon CD, van Lonkhuijzen LRCW, Massuger LFAG, Smolders RGV, van Trommel NE, Yigit R, Zweemer RP, van der Aa MA. Wenzel HHB, et al. Among authors: yigit r. Acta Obstet Gynecol Scand. 2020 Jul;99(7):925-932. doi: 10.1111/aogs.13812. Epub 2020 Feb 6. Acta Obstet Gynecol Scand. 2020. PMID: 31955408
First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers.
Komdeur FL, Singh A, van de Wall S, Meulenberg JJM, Boerma A, Hoogeboom BN, Paijens ST, Oyarce C, de Bruyn M, Schuuring E, Regts J, Marra R, Werner N, Sluis J, van der Zee AGJ, Wilschut JC, Allersma DP, van Zanten CJ, Kosterink JGW, Jorritsma-Smit A, Yigit R, Nijman HW, Daemen T. Komdeur FL, et al. Among authors: yigit r. Mol Ther. 2020 Nov 5:S1525-0016(20)30600-6. doi: 10.1016/j.ymthe.2020.11.002. Online ahead of print. Mol Ther. 2020. PMID: 33160073 Free article.
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.
Koole S, van Stein R, Sikorska K, Barton D, Perrin L, Brennan D, Zivanovic O, Mosgaard BJ, Fagotti A, Colombo PE, Sonke G, Driel WJV; OVHIPEC-2 Steering Committee and the Dutch OVHIPEC group. Koole S, et al. Int J Gynecol Cancer. 2020 Jun;30(6):888-892. doi: 10.1136/ijgc-2020-001231. Epub 2020 Mar 23. Int J Gynecol Cancer. 2020. PMID: 32205449
17 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback